Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Programmed death 1 (PD-1) and its ligands (PD-L1, PD-L2) typically regulate immune responses.
• While PD-1 is known on immune cells, its expression within tumor cells is increasingly recognized.

Purpose of the Study:

• To investigate the intrinsic roles of PD-1 expression in various cancer cells.
• To understand how tumor-intrinsic PD-1 signaling affects tumor growth and therapeutic outcomes.

Main Methods:

• Reanalysis of cancer transcriptomic and proteomic data.
• Review of existing studies on PD-1 expression and function in different cancer types.

Main Results:

• PD-1 is intrinsically expressed in melanoma, liver, and lung cancer cells.
• In melanoma and liver cancer, PD-1 signaling promotes tumor growth.
• In lung cancer, PD-1 blockade paradoxically enhances tumor cell proliferation.

Conclusions:

• Tumor-intrinsic PD-1 has multifaceted roles beyond immune checkpoint inhibition.
• Understanding these roles is crucial for explaining differential drug responses and developing combination therapies for enhanced antitumor immunity.